Results 61 to 70 of about 4,877,549 (387)
Analysis of lncRNA sequences: FAM3D-AS1, LINC01230, LINC01315 and LINC01468 in endometrial cancer
BMC Cancer, 2022 Background The analysis of long non-coding RNA (lncRNA) in endometrial cancer is a novel field of science. Although numerous lncRNA sequences have been identified until today, their correlation with endometrial cancer is still undetermined.
Jan Bieńkiewicz +7 more
doaj +1 more source
Prognostic value of angiogenic markers of endometrial cancer (literature review)
Сибирский онкологический журнал, 2022 Endometrial cancer is the most common cancer of the female reproductive organs. The purpose of the study was to summarize the available data on the role of angiogenic markers in the development, progression and prognosis of endometrial cancer.
N. S. Zolotukhina, L. F. Gulyaeva
doaj +1 more source
Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations [PDF]
, 2014 Somatic mitochondrial DNA (mtDNA) mutations have been found in a subset of endometrial cancers (EC) from different populations. We have investigated the relationship between mtDNA changes and clinical and pathological variables of women affected by ...
Bartnik, Ewa +6 more
core +1 more source
Survival outcome in endometrial cancer patients according to hereditary predisposition
Taiwanese Journal of Obstetrics & Gynecology, 2015 Objective: A familial history of ovarian cancer/breast cancer is considered a significant prognostic factor for ovarian cancer. We investigated hereditary factors by examining the incidence of synchronous malignancy in patients with endometrial cancer ...
Heon Jong Yoo +7 more
doaj +1 more source
Chinese Medical Journal, 2021 . Background. Endometrial cancer is one of the most common malignancies of the reproductive system. Effective and cost-effective screening method for populations at high risk is not available.
Guo Zhang +8 more
doaj +1 more source
Metformin as a Therapeutic Target in Endometrial Cancers. [PDF]
, 2018 Endometrial cancer is the most common gynecologic malignancy in developed countries. Its increasing incidence is thought to be related in part to the rise of metabolic syndrome, which has been shown to be a risk factor for the development of ...
Johnson, Jennifer +6 more
core +2 more sources
Patterns of care and outcomes for endometrial and ovarian cancers in botswana 2015–2021
Gynecologic Oncology Reports, 2023 Purpose: Endometrial and ovarian cancers are leading causes of cancer death among women. However, there is little data on these patients from low- and middle-income countries including Botswana, a country in sub-Saharan Africa. This study reports data on
Christian Lumley +13 more
doaj +1 more source
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer [PDF]
, 2017 Background: More information is needed for selection of patients with peritoneal metastases from endometrial cancer (EC) to undergo cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: This study analyzed clinical,
Biacchi, Daniele +9 more
core +1 more source
JAMA Oncology, 2020 Key Points Question What is the clinical antitumor activity and safety of dostarlimab for patients with deficient mismatch repair endometrial cancer? Findings In this nonrandomized phase 1 clinical trial, the confirmed objective response rate was 42%; 13%
A. Oaknin +14 more
semanticscholar +1 more source
Risk factors for endometrial cancer: An umbrella review of the literature
International Journal of Cancer, 2019 Although many risk factors could have causal association with endometrial cancer, they are also prone to residual confounding or other biases which could lead to over‐ or underestimation.
O. Raglan +10 more
semanticscholar +1 more source